Author

Daniel Craig

International AIDS Vaccine Initiative

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:E. coli· 1 Assay:protein structure· 1

Frequent Co-Authors

Albert E. Price· 2 shared Sam PallerlaiD· 2 shared Amber Costakes· 1 shared Andrew B. WardiD· 1 shared Christopher A. CottrelliD· 1 shared Derek Ryan· 1 shared Eu-min Kim· 1 shared Ferenc L. BoldogiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Albert E. Price

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Scalable Production of a De Novo SARS-CoV-2 Antiviral miniprotein in Escherichia coli

Jinhwan Shin, Eu-min Kim, Jun-Hong Jang, Seok-won Jee, Sang-Hoon Kim, Seong Gwan Yu, Minguen Yoon, Daniel Craig, Ryan Swoyer, Sandip Patel, Praveen Alamuri, Albert E. Price, Rashmi Ravichandran, Lauren P. Carter, Sam Pallerla

This paper describes the scalable production of a de novo SARS-CoV-2 antiviral miniprotein in E. coli, achieving high purity and yield for preclinical and clinical use.

Pharmaceutics · Sep 3, 2026Peer-reviewedBioengineering

Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144

Sam Pallerla, Shaunak D. Uplekar, Ferenc L. Boldog, James C. Paulson, Sabyasachi Baboo, John R. Yates, Wen-Hsin Lee, Gabriel Ozorowski, Joel D. Allen, Max Crispin, Christopher A. Cottrell, Andrew B. Ward, Varsha Sitaraman, Tim Broderick, Amber Costakes, , William R. Schief

This paper describes the development and cGMP manufacturing of an HIV vaccine candidate for clinical trials, demonstrating scalable production and quality control.

bioRxiv · Jun 16, 2026 · PreprintBioengineering